Africare in Nigeria will convene a stakeholder summit on April 12th in Abuja to release the results of a six-year malaria prevention program in Nigeria that was implemented with the support of ExxonMobil.
“The Africare MAPS-C project has helped advance our goals of working with partners to provide malaria prevention therapies to communities in Nigeria and helping to improve health infrastructure,” said Kevin Murphy, president of ExxonMobil Foundation. “We were proud to support Africare in training health workers in electronic data capture and timely sharing of health information.”
The Malaria Prevention in Mobil Producing Nigeria Supplier Communities (MAPS-C) project ran from 2011 through 2017 and was focused on four local government areas in Akwa Ibom and Rivers States (Eket, Ibeno, Bonny and Ogu/Bolo) reaching over 90,000 people. Beneficiaries included children under five and pregnant women in households within these communities.
Among the top-line results of the evaluation of the MAPS-C project, it was found that:
- The percentage of under-five children who received Artemisinin-based Combination Therapy (ACT) as a treatment for malaria increased from 21% at the start of the project, to 74% in 2016
- Percentage of persons with suspected malaria that were tested increased from less than 30% at the start of the project, to more than 90% in 2016.
- Overtreatment reduced from 97% in 2015 to 2% in 2017
- Awareness increased from about 30% to over 80% (the target in the National Malaria Elimination Strategy for Nigeria)
For more details and statistics on Africare’s work, click here Africare-2pgr-v3MAPS-C Nigeria Digital